value stocks will need to see a vaccine to move up: ubs
Published 3 years ago • 127 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
4:56
growth stocks won't see vast outperformance with slowing economy, says trivariate's parker
-
2:43
nvidia's stock is not priced for perfection and there is more to go: analyst
-
5:29
has nvidia's stock been too priced to perfection? two top investors weigh in
-
3:22
cresset's jack ablin weighs in on nvidia's potential to move the market
-
4:01
the market will continue to move on virus-related news, and we see some signs of optimism: haefele
-
5:33
market gears up for nvidia earnings: here's what to expect
-
11:21
why the vaccine rollout is failing poorer countries | cnbc reports
-
6:34
slowing income growth has led to increased consumer prudence, says ey-parthenon's greg daco
-
7:12
how these investors are shifting from growth to value stocks
-
2:14
economies will continue to recover despite omicron variant: ubs
-
2:58
ubs sees strong global economic recovery from the coronavirus pandemic
-
1:58
hundreds of flights canceled, thousands delayed as labor day travel rush begins
-
6:01
why a 50bps rate cut could 'work against the economy': economist
-
44:55
how netflix and youtube changed entertainment forever | cnbc marathon
-
2:43
target will have a much better 2023, says ubs's michael lasser
-
9:03
how mistakes redefined the vaccine process | cnbc explains
-
6:10
coronavirus: vir ceo on partnering with gsk to develop treatments, vaccines
-
6:55
should you invest in a vaccine company? | money mind | vaccine stocks
-
10:15
how u.s. airlines transport covid-19 vaccines
-
4:43
investors need to embrace for earnings pain ahead, says ubs's julie fox
-
3:06
pfizer's covid vaccine approval adds certainty to the stock: mizuho analyst
-
2:31
jim cramer on how j&j's stock has performed in relation to vaccine news